Abstract:Background: Previous studies have demonstrated that Tc-99m-sestamibi (Tc-99m- MIBI) Single-Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) imaging is an effective isotopic technique for locating the parathyroid in secondary hyperparathyroidism (SHPT). This study aimed to explore further the correlation between Tc-99m-MIBI SPECT/CT imaging and SHPT to demonstrate the value of Tc-99m-MIBI SPECT/CT in evaluating the degree of pathological hyperplasia of the parathyroid gland (PG). Methods: The demographics, surgical records, and follow-up information of 91 patients were recorded and analyzed. A total of 216 paraffin-embedded PGs of 54 patients were obtained and analyzed. Results: Patients with Tc-99m-MIBI negative PG(s) had significantly lower preoperative serum phosphorus and higher serum calcium levels at 6 months postoperatively compared to those with Tc-99m-MIBI positive PG(s) (P<0.05). We also found a higher total uptake ratio of the region of interest (URRI) and higher URRI max in the hypocalcemia group than in the non-hypocalcemia group. Both URRI total (P=0.003) and URRI max (P=0.028) were independent risk factors for hypocalcemia 6 months postoperatively. The URRI values of the PGs were significantly positively correlated with glandular weight (R-2=0.343, P<0.001), glandular volume (R-2=0.240, P<0.001), and degree of pathological hyperplasia (P<0.001). However, the URRI value of the PGs exhibited a notably weak correlation with proliferating cell nuclear antigen (PCNA) (R-2=0.035, P=0.006). The area under the receiver operating characteristic curve showed a URRI evaluative value of 0.771 for diffuse and nodular types in 216 PGs (P<0.001). We further evaluated 167 nodular-type PGs, distinguishing between nodular hyperplasia and a single nodule; the URRI evaluative value reached 0.819, which was higher than the volume or weight (P<0.001). Conclusions: The Tc-99m-MIBI SPECT/CT scintigraphy results were related to serum calcium levels at 6 months after total parathyroidectomy with autotransplantation (TPTX+AT), suggesting the occurrence of hypocalcemia (6 months after TPTX+AT). More importantly, this technique effectively evaluated the pathological hyperplasia of PGs preoperatively, and therefore, could assist surgeons in selecting the PGs with the lowest degree of hyperplasia intraoperatively.

Progress of Gene in Sporadic Parathyroid Adenomas

Preliminary Study on Gene Expression Profiles of Sporadic Parathyroid Adenoma with Application of Gene-Chip Technology

Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population

Advances in the molecular genetics of parathyroid tumors

Integrated Whole-Exome and Transcriptome Sequencing of Sporadic Parathyroid Adenoma

Expression of Β-Catenin and Cyclin-D1 in Sporadic Parathyroid Adenomas

Whole-Exome Sequencing Identifies Novel Recurrent Somatic Mutations in Sporadic Parathyroid Adenomas

Molecular and Clinical Spectrum of Primary Hyperparathyroidism

Single-Cell Transcriptomic Atlas of Parathyroid Adenoma and Parathyroid Carcinoma.

Heterogeneous Transcriptional Landscapes in Human Sporadic Parathyroid Gland Tumors

Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors

Genetic Alteration Profiles and Clinicopathological Associations in Atypical Parathyroid Adenoma

Study on clinical characteristics and misdiagnosis of parathyroid adenoma-analysis of 9 cases.

Parathyroid Adenoma Complicated with Primary Hyperparathyroidism: a Report of Two Cases

Clinical imaging analysis of parathyroid adenoma

[Diagnosis and Treatment of Osteopathic Parathyroid Adenoma].

Analysis of the Successful Clinical Treatment of 140 Patients with Parathyroid Adenoma: A Retrospective Study

Research Progress in Invasive Pituitary Adenomas Related Tumor Suppressor Gene

RNA-sequence Reveals Differentially Expressed Genes Affecting the Secondary Hyperparathyroidism

Recent progress in diagnosis and treatment of hyperparathyroidism

Use of 99Mtc-Sestamibi SPECT/CT Imaging in Predicting the Degree of Pathological Hyperplasia of the Parathyroid Gland: Semi-Quantitative Analysis.